Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jun 21;30(9):1660–1668. doi: 10.1158/1055-9965.EPI-21-0162

Table 4.

Odds ratios and 95% CIs for the association between frequency of genital powder use and ovarian cancer, overall and by race, stratified by histotype

All cases High-grade serous All other histotypes
Frequency of usea Controls (%) Cases (%) MVb
OR (95% CI)c
Cases (%) MVb
OR (95% CI)c
Cases (%) MVb
OR (95% CI)c
All participants
No genital use 3213 (78.4) 2047 (72.5) 1.00 1229 (72.3) 1.00 796 (72.6) 1.00
≤ once per week 117 (2.9) 103 (3.7) 1.34 (1.01–1.79) 65 (3.8) 1.34 (0.95–1.87) 37 (3.4) 1.29 (0.87–1.92)
> once per week 747 (18.2) 650 (23.0) 1.31 (1.15–1.48) 389 (22.9) 1.31 (1.13–1.52) 257 (23.5) 1.29 (1.09–1.54)
ptrendd 0.98 0.88 0.79
African Americans
No genital use 700 (69.5) 391 (65.6) 1.00 249 (64.7) 1.00 140 (67.0) 1.00
≤ once per week 35 (3.5) 23 (3.9) 1.23 (0.68–2.21) 14 (3.6) 1.18 (0.59–2.36) 09 (4.3) 1.21 (0.64–3.07)
> once per week 272 (27.0) 182 (30.5) 1.22 (0.96–1.55) 122 (31.7) 1.34 (1.02–1.76) 60 (28.7) 1.02 (0.71–1.45)
ptrendd 0.85 0.68 0.77
Whites
No genital use 2513 (81.9) 1656 (75.1) 1.00 980 (75.5) 1.00 656 (74.5) 1.00
≤ once per week 82 (2.7) 80 (3.6) 1.40 (1.00–1.96) 51 (3.9) 1.42 (1.00–2.12) 28 (3.2) 1.32 (0.84–2.08)
> once per week 475 (15.5) 468 (21.2) 1.34 (1.16–1.56) 267 (20.6) 1.29 (1.08–1.54) 197 (22.4) 1.40 (1.15–1.71)
ptrendd 0.90 0.68 0.66
a

Frequency of use variable includes the following study sites: AACES, CCCS, NCOCS, LACOCS

b

MV=Multivariable

c

Adjusted for age (continuous), education (high school graduate/GED or less, some college, college graduate, graduate/professional school), duration of OC use (months, continuous), family history of breast cancer (no, yes, family history of ovarian cancer (no, yes), tubal ligation (yes, no), full term pregnancies (number of pregnancies ≥ 6 months, continuous), hysterectomy (no, yes), interview year (continuous), BMI (<25.0, 25.0–29.9, 30.0–34.9, ≥35.0), menopausal (premenopausal, postmenopausal), smoking (ever, never), study site (AACES, CCCS, NCOCS, LACOCS, WHI)

d

Determined using category median values